---
figid: PMC6332919__SCIENTIFICA2018-5036213.001
figtitle: MAPK signalling pathway and its inhibitors
organisms:
- Homo sapiens
organisms_ner:
- NA
pmcid: PMC6332919
filename: SCIENTIFICA2018-5036213.001.jpg
figlink: /pmc/articles/PMC6332919/figure/fig1/
number: F1
caption: MAPK signalling pathway and its inhibitors.
papertitle: Cutaneous Side Effects of Targeted Therapy and Immunotherapy for Advanced
  Melanoma.
reftext: Irene Russo, et al. Scientifica (Cairo). 2018;2018:5036213.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9223481
figid_alias: PMC6332919__F1
figtype: Figure
redirect_from: /figures/PMC6332919__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6332919__SCIENTIFICA2018-5036213.001.html
  '@type': Dataset
  description: MAPK signalling pathway and its inhibitors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tyrosine
  - Vemurafenib
  - Dabrafenib
  - Trametinib
  - Cobimetinib
---
